id	sid	eid	entity	type
bptjm-21	7	1	1	CARDINAL
bptjm-21	8	1	dujwbujpo	PRODUCT
bptjm-21	8	2	1pufoujbm	CARDINAL
bptjm-21	8	3	berkeley pharma tech journal	ORG
bptjm-21	8	4	2	CARDINAL
bptjm-21	8	5	202	CARDINAL
bptjm-21	8	6	20	CARDINAL
bptjm-21	8	7	1vcmjtife	CARDINAL
bptjm-21	8	8	4.0	CARDINAL
bptjm-21	8	9	3.0	CARDINAL
bptjm-21	9	1	csr	ORG
bptjm-21	9	2	gc)4	PERSON
bptjm-21	9	3	csr	ORG
bptjm-21	9	4	antibodies5	GPE
bptjm-21	10	1	gc	ORG
bptjm-21	10	2	genes5	PERSON
bptjm-21	11	1	aicda	PERSON
bptjm-21	11	2	1	CARDINAL
bptjm-21	12	1	responses7	PERSON
bptjm-21	13	1	csr	ORG
bptjm-21	16	1	9	CARDINAL
bptjm-21	18	1	1	CARDINAL
bptjm-21	22	1	two	CARDINAL
bptjm-21	23	1	ab diversi	ORG
bptjm-21	23	2	csr	ORG
bptjm-21	24	1	aid11	GPE
bptjm-21	25	1	berkeley pharma tech journal	ORG
bptjm-21	25	2	108	CARDINAL
bptjm-21	25	3	1	CARDINAL
bptjm-21	27	1	malignancies15	GPE
bptjm-21	28	1	chromosomalrearrangements16	GPE
bptjm-21	32	1	17	CARDINAL
bptjm-21	33	1	berkeley pharma tech journal	ORG
bptjm-21	34	1	109	CARDINAL
bptjm-21	38	1	2	CARDINAL
bptjm-21	39	1	nearly two decades	DATE
bptjm-21	40	1	2	CARDINAL
bptjm-21	41	1	berkeley pharma tech journal	ORG
bptjm-21	42	1	110	CARDINAL
bptjm-21	46	1	strands4	PERSON
bptjm-21	48	1	strands4	PERSON
bptjm-21	50	1	repair7	WORK_OF_ART
bptjm-21	52	1	structure23	ORG
bptjm-21	54	1	one	CARDINAL
bptjm-21	54	2	dc	GPE
bptjm-21	55	1	surface10	GPE
bptjm-21	56	1	one	CARDINAL
bptjm-21	56	2	two	CARDINAL
bptjm-21	56	3	one	CARDINAL
bptjm-21	57	1	berkeley pharma tech journal	ORG
bptjm-21	57	2	111	CARDINAL
bptjm-21	58	1	csr	ORG
bptjm-21	62	1	developed10	ORG
bptjm-21	69	1	states25	EVENT
bptjm-21	70	1	one	CARDINAL
bptjm-21	70	2	cancer25	GPE
bptjm-21	72	1	berkeley pharma tech journal	ORG
bptjm-21	73	1	hoxc4	ORG
bptjm-21	73	2	activation6	PERSON
bptjm-21	75	1	hdi	ORG
bptjm-21	75	2	ab	GPE
bptjm-21	75	3	mir-26a	DATE
bptjm-21	75	4	3’utr6	CARDINAL
bptjm-21	76	1	scfa hdis	PERSON
bptjm-21	77	1	lupus2	PRODUCT
bptjm-21	78	1	response6	GPE
bptjm-21	80	1	three	CARDINAL
bptjm-21	81	1	processes14	LOC
bptjm-21	83	1	ipsc technology	ORG
bptjm-21	84	1	reprogramming14	GPE
bptjm-21	86	1	berkeley pharma tech journal	ORG
bptjm-21	86	2	113	CARDINAL
bptjm-21	86	3	one	CARDINAL
bptjm-21	86	4	cvid	NORP
bptjm-21	89	1	nearly 50%	PERCENT
bptjm-21	91	1	gc	ORG
bptjm-21	91	2	il-21	ORG
bptjm-21	92	1	preeclampsia31	PERSON
bptjm-21	95	1	process32	PERSON
bptjm-21	96	1	patients32	ORG
bptjm-21	97	1	ms32	PERSON
bptjm-21	97	2	myelin oligodendrocyte	PERSON
bptjm-21	97	3	trajectory32	GPE
bptjm-21	100	1	mice33	PERSON
bptjm-21	101	1	berkeley pharma tech journal	ORG
bptjm-21	101	2	114	CARDINAL
bptjm-21	102	1	mice33	PERSON
bptjm-21	106	1	more than 40%	PERCENT
bptjm-21	106	2	cll	ORG
bptjm-21	106	3	4,4’-diisothiocyanatostilbene-2-2’-disulfonic	CARDINAL
bptjm-21	109	1	avenue	GPE
bptjm-21	109	2	progression18	NORP
bptjm-21	110	1	18	CARDINAL
bptjm-21	111	1	sirna	PERSON
bptjm-21	111	2	lymphocytes15	GPE
bptjm-21	113	1	berkeley pharma tech journal	ORG
bptjm-21	113	2	115	CARDINAL
bptjm-21	117	1	berkeley pharma tech journal	ORG
bptjm-21	117	2	116	CARDINAL
bptjm-21	117	3	1	CARDINAL
bptjm-21	118	1	alvarez-gonzalez j	PERSON
bptjm-21	118	2	yasgar	PERSON
bptjm-21	120	1	acs pharmacol transl sci	ORG
bptjm-21	121	1	2021;4(3):1214-1226	CARDINAL
bptjm-21	122	1	2021	CARDINAL
bptjm-21	123	1	2	CARDINAL
bptjm-21	123	2	briney bs	PERSON
bptjm-21	123	3	crowe je jr.	PERSON
bptjm-21	125	1	2013	DATE
bptjm-21	126	1	3	CARDINAL
bptjm-21	128	1	2015;43(5):884-895	CARDINAL
bptjm-21	129	1	doi:10.1016	GPE
bptjm-21	130	1	chen y	PERSON
bptjm-21	130	2	dale bl	PERSON
bptjm-21	130	3	alexander mr	PERSON
bptjm-21	130	4	et al	PERSON
bptjm-21	131	1	cardiovasc	ORG
bptjm-21	132	1	2021;117(4):1217-1228	CARDINAL
bptjm-21	133	1	5	CARDINAL
bptjm-21	134	1	dale bl	PERSON
bptjm-21	134	2	pandey ak	ORG
bptjm-21	134	3	chen y	PERSON
bptjm-21	134	4	21	CARDINAL
bptjm-21	135	1	jci	ORG
bptjm-21	136	1	2019	CARDINAL
bptjm-21	137	1	6	CARDINAL
bptjm-21	137	2	de carvalho dd	PERSON
bptjm-21	137	3	jones pa	PERSON
bptjm-21	139	1	2010;20(10):609-617	CARDINAL
bptjm-21	140	1	doi:10.1016/j.tcb.2010.08.003 7	ORG
bptjm-21	140	2	del pino molina l	PERSON
bptjm-21	140	3	jm, pernía o	ORG
bptjm-21	140	4	rodríguez pena	PERSON
bptjm-21	140	5	lópez granados e. defective bcl-2	PERSON
bptjm-21	141	1	clin	PERSON
bptjm-21	142	1	2021;203(3):341-350	CARDINAL
bptjm-21	143	1	doi:10.1111/cei.13522 8	ORG
bptjm-21	144	1	galicia g	PERSON
bptjm-21	144	2	lee dsw	PERSON
bptjm-21	145	1	j immunol	PERSON
bptjm-21	147	1	9	CARDINAL
bptjm-21	147	2	han l	ORG
bptjm-21	147	3	yu k. overlapping activation	PERSON
bptjm-21	148	1	sci u s a. 2011;108(28):11584-11589	ORG
bptjm-21	150	1	10	CARDINAL
bptjm-21	150	2	hu y	PERSON
bptjm-21	150	3	doseth	PERSON
bptjm-21	150	4	liabakk nb	PERSON
bptjm-21	150	5	kavli b. activation	PERSON
bptjm-21	152	1	2014;322(1):178-192	CARDINAL
bptjm-21	154	1	jeong gs	PERSON
bptjm-21	154	2	li	PERSON
bptjm-21	154	3	lee ds	PERSON
bptjm-21	154	4	kim yc	PERSON
bptjm-21	155	1	2014	DATE
bptjm-21	157	1	2010;33(8):1269-1275	PRODUCT
bptjm-21	159	1	kelly c	PERSON
bptjm-21	159	2	gangur	ORG
bptjm-21	160	1	cairo	GPE
bptjm-21	161	1	2009;2009:159845	CARDINAL
bptjm-21	163	1	kim	PERSON
bptjm-21	163	2	han l	GPE
bptjm-21	163	3	yu k.	PERSON
bptjm-21	165	1	2020;40(16):e00125-20	CARDINAL
bptjm-21	166	1	2020 jul 29	DATE
bptjm-21	167	1	20	CARDINAL
bptjm-21	167	2	berkeley pharma tech journal	ORG
bptjm-21	167	3	117 14	DATE
bptjm-21	168	1	lamont kr	PERSON
bptjm-21	168	2	donghia	PERSON
bptjm-21	171	1	1033	CARDINAL
bptjm-21	172	1	jem.20121258 15	WORK_OF_ART
bptjm-21	173	1	liu jq	PERSON
bptjm-21	173	2	joshi ps	PERSON
bptjm-21	173	3	wang	PERSON
bptjm-21	174	1	ctls	GPE
bptjm-21	175	1	j immunol	PERSON
bptjm-21	176	1	2010;184(10):5435-5443	DATE
bptjm-21	177	1	16	CARDINAL
bptjm-21	178	1	meshcheryakova	PERSON
bptjm-21	178	2	zimmermann p	ORG
bptjm-21	178	3	rogozin ib	PERSON
bptjm-21	178	4	covid-19	DATE
bptjm-21	180	1	2021;12:690416	CARDINAL
bptjm-21	180	2	2021	CARDINAL
bptjm-21	180	3	jul 1	DATE
bptjm-21	181	1	17	CARDINAL
bptjm-21	182	1	miyazaki y	PERSON
bptjm-21	182	2	inoue h	PERSON
bptjm-21	182	3	kikuchi k	PERSON
bptjm-21	182	4	ochiai k	PERSON
bptjm-21	182	5	kusama k. activation-	PERSON
bptjm-21	183	1	sci	ORG
bptjm-21	184	1	2012;54(1):71-75	CARDINAL
bptjm-21	184	2	18	CARDINAL
bptjm-21	184	3	abreu c	PERSON
bptjm-21	188	1	19	CARDINAL
bptjm-21	189	1	morgan hd	ORG
bptjm-21	189	2	dean w	PERSON
bptjm-21	189	3	reik w	ORG
bptjm-21	189	4	petersen-mahrt	ORG
bptjm-21	189	5	5	CARDINAL
bptjm-21	191	1	2004;279(50):52353-52360	DATE
bptjm-21	192	1	20	CARDINAL
bptjm-21	193	1	moroney jb	PERSON
bptjm-21	193	2	xu	PERSON
bptjm-21	194	1	zan	PERSON
bptjm-21	194	2	casali p. epigenetics	ORG
bptjm-21	195	1	curr opin	PERSON
bptjm-21	195	2	immunol	PERSON
bptjm-21	196	1	2020;67:75-86	CARDINAL
bptjm-21	197	1	doi:10.1016/j.coi.2020.09.004 21	ORG
bptjm-21	198	1	pham p	ORG
bptjm-21	201	1	2016;43:48-56	CARDINAL
bptjm-21	201	2	doi:10.1016	GPE
bptjm-21	201	3	22	CARDINAL
bptjm-21	202	1	qiao q	PERSON
bptjm-21	202	2	wang l	PERSON
bptjm-21	202	3	meng fl	PERSON
bptjm-21	202	4	hwang jk	PERSON
bptjm-21	202	5	wu h.	PERSON
bptjm-21	205	1	doi:10.1016/j.molcel.2017.06.034 23	FAC
bptjm-21	206	1	rada c	PERSON
bptjm-21	206	2	di noia jm	PERSON
bptjm-21	206	3	neuberger ms	PERSON
bptjm-21	206	4	mismatch	PERSON
bptjm-21	208	1	2004;16(2):163-171	CARDINAL
bptjm-21	210	1	24	CARDINAL
bptjm-21	211	1	ratiu jj	PERSON
bptjm-21	211	2	racine jj	PERSON
bptjm-21	212	1	1	CARDINAL
bptjm-21	213	1	j immunol	PERSON
bptjm-21	214	1	2017;198(11):4255-4267	DATE
bptjm-21	215	1	25	CARDINAL
bptjm-21	216	1	sanchez hn	PERSON
bptjm-21	216	2	moroney jb	PERSON
bptjm-21	216	3	gan h	ORG
bptjm-21	218	1	nat commun	PERSON
bptjm-21	219	1	2020;11(1):60	CARDINAL
bptjm-21	219	2	2020	DATE
bptjm-21	219	3	jan 2	DATE
bptjm-21	219	4	doi:10.1038	ORG
bptjm-21	219	5	6 26	CARDINAL
bptjm-21	220	1	saribasak h	ORG
bptjm-21	220	2	gearhart pj	PERSON
bptjm-21	222	1	semin immunol	PERSON
bptjm-21	223	1	2012;24(4):287	CARDINAL
bptjm-21	223	2	27	CARDINAL
bptjm-21	224	1	wang r	PERSON
bptjm-21	224	2	zhang x	PERSON
bptjm-21	225	1	lett	PERSON
bptjm-21	226	1	berkeley pharma tech journal	ORG
bptjm-21	226	2	118	CARDINAL
bptjm-21	228	1	whelton pk	PERSON
bptjm-21	228	2	carey rm	PERSON
bptjm-21	228	3	2017	CARDINAL
bptjm-21	228	4	acc/aha	ORG
bptjm-21	228	5	the american college of cardiology/american heart association task force	ORG
bptjm-21	229	1	2018	DATE
bptjm-21	231	1	2018	DATE
bptjm-21	233	1	2018;71(6):1269-1324	CARDINAL
bptjm-21	235	1	pone ej	PERSON
bptjm-21	237	1	j immunol.2014;193(12):5933-5950	PERSON
bptjm-21	238	1	29	CARDINAL
bptjm-21	239	1	yamanaka s	PERSON
bptjm-21	239	2	blau	PERSON
bptjm-21	240	1	three	CARDINAL
bptjm-21	242	1	2010;465(7299):704-712	ORG
bptjm-21	242	2	doi:10.1038/nature09229 30	ORG
bptjm-21	243	1	yewdell wt	PERSON
bptjm-21	243	2	chaudhuri j.	PERSON
bptjm-21	246	1	2017;29(4):183-196	CARDINAL
bptjm-21	247	1	31	CARDINAL
bptjm-21	249	1	lieber	PERSON
bptjm-21	250	1	crit rev biochem mol biol	ORG
bptjm-21	251	1	2019;54(4):333-351	CARDINAL
bptjm-21	252	1	32	CARDINAL
bptjm-21	253	1	zan	PERSON
bptjm-21	255	1	2013;46(2):83-101	CARDINAL
bptjm-21	256	1	33	CARDINAL
bptjm-21	257	1	zhu j	PERSON
bptjm-21	257	2	potter aa	PERSON
bptjm-21	259	1	j immunol	PERSON
bptjm-21	260	1	2020;204(5):1091-1100	DATE
bptjm-21	261	1	berkeley pharma tech journal	ORG
bptjm-21	261	2	119	CARDINAL